BRIEF published on 12/05/2025 at 08:05, 1 hour 29 minutes ago Molten Ventures Executes Share Buyback Ordinary Shares Share Buyback Stock Market Molten Ventures Goodbody Stockbrokers
PRESS RELEASE published on 12/05/2025 at 08:00, 1 hour 34 minutes ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 50,000 ordinary shares on 4 Dec 2025 as part of the share repurchase program. Details of the transaction included Ordinary Shares Molten Ventures Plc Share Repurchase Program Goodbody Stockbrokers UC LSE: GROW
BRIEF published on 12/04/2025 at 17:45, 15 hours 49 minutes ago Molten Ventures Plc Sees BlackRock Reduce Stake Voting Rights Investment Strategy Financial Instruments Molten Ventures BlackRock Holdings
BRIEF published on 12/04/2025 at 17:45, 15 hours 49 minutes ago Bank of America Increases Stake in Molten Ventures Voting Rights Investment Strategy Financial Instruments Molten Ventures Bank Of America
PRESS RELEASE published on 12/04/2025 at 17:40, 15 hours 54 minutes ago Holding(s) in Company BlackRock, Inc. notified an acquisition of voting rights in Molten Ventures Plc on 03-Dec-2025 Acquisition Voting Rights Molten Ventures Plc Notification BlackRock, Inc.
PRESS RELEASE published on 12/04/2025 at 17:40, 15 hours 54 minutes ago Holding(s) in Company Bank of America Corporation acquires 5.02% voting rights in Molten Ventures Plc. Regulatory notification submitted on 03-Dec-2025. Financial instruments used for acquisition Acquisition Molten Ventures Plc Financial Instruments Bank Of America Corporation Regulatory Notification
BRIEF published on 12/04/2025 at 08:05, 1 day 1 hour ago Molten Ventures Announces Share Repurchase Activity Share Repurchase Financial Announcement Market Activity Stock Buyback Molten Ventures
PRESS RELEASE published on 12/04/2025 at 08:00, 1 day 1 hour ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) reports purchasing 50,000 of its own ordinary shares at prices ranging from 456.00p to 463.60p with a volume-weighted average price of 458.1145p on 3 Dec 2025 Share Repurchase Ordinary Shares Molten Ventures Plc Goodbody Stockbrokers UC LSE: GROW
BRIEF published on 12/03/2025 at 08:05, 2 days 1 hour ago Molten Ventures Share Repurchase Details Share Repurchase Stock Market Financial Regulation Molten Ventures Investor Information
PRESS RELEASE published on 12/03/2025 at 08:00, 2 days 1 hour ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) announces the purchase of 50,000 ordinary shares at prices ranging from 455.40p to 461.00p in the share repurchase program Share Repurchase Ordinary Shares Molten Ventures Plc Goodbody Stockbrokers UC LSE: GROW
Published on 12/05/2025 at 02:35, 6 hours 59 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 34 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 29 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 34 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:05, 29 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 49 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 34 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 15 hours 49 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 15 hours 50 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
